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Accepted 7 March 2015In the body L-glutamine is abundant and required for the proliferation of cells. Indeed human physiology
is dependent upon having and maintaining the correct glutamine levels for a range of functions including
neurological signalling and a healthy immune system. However, during tumourigenesis cell proliferation
demands elevated levels of glutamine, which can ultimately lead to muscle atrophy. In some cases the
skin provides the first indications of the underlying disease and erupts in a wave of complicated pattern
formations. One such skin marker is erythema gyratum repens. We investigated the pattern formations
associated with concentrations of glutamine in aqueous solutions at levels higher than that of a normal
biological functionality. We find remarkable similarities between the patterns of erythema gyratum
repens and the unusual self-assembled patterns of glutamine. The findings may lead to new therapeutics
and understanding for those working in oncology and toxicology. Utilising the formations associated with
glutamine could also assist in bio-functionalising micro and nanoparticles for high efficacy.
 2015 The Author. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).Introduction
There are many cases of diseases or symptoms arising as a pre-
cursor or marker of a more serious ailment [1]. For example, a
paraneoplastic syndrome such as erythema gyratum repens
(EGR) sometimes emerges as a result of the presence of a cancer
in the body, even though it is not due to an immediate local pres-
ence of a cancer to the skin. The patterns on the skin can be
remarkable including concentric rings and fractal-like geometries.
They emerge as a result of a change in body chemistry due to
excretions by the tumour cells or an immune response. The healthy
structure of the skin can also become disorganised with illness [2].
In the case of EGR the whole body can become covered, with an
advance of about 1 cm/day, that persists with advancing serpigi-
nous trails [3,4] and nonspecific histopathologic features [4].
Here we hypothesise a link between L-glutamine and EGR, for
those with access to facilities to carry out mass spectrometric
analyses of biopsied specimens from each ring and normal skin
between rings from EGR. This should be done for quantitative
determination of L-glutamine. It should be noted throughout that
the size of the effect is scalable with the volume of liquid across
a surface but is explored under the microscope for sample sizes
up to several centimetres.
We find that the polycyclic rash has all the hall-marks associ-
ated with elevated levels of L-glutamine (gln). As the mostabundant free amino acid found in the body [5] it has an important
functionality for the healthy growth of normal and neoplastic cells.
But cancer is also glutamine hungry and so thrives on the transport
of the amino acid into tumour mitochondria [6]. The continual per-
fusion of 0.5 mmol of glutamine creates a steady state condition
whereby one glutamate is released for each glutamine absorbed
[6,7]. Thus the cancer acts as a factory that depletes the levels of
glutamine in the body. The reach of malignant proliferation peaks
just after the tumour amidohydrolase enzyme glutaminase
maximum in expression and activity (giving the reaction,
gln + H2O? glutamate(glu) ± NH3) [6]. Thus, the first physical
signs of tumour harvesting of gln could be the reaction of the skin,
such as in EGR, which is a situation corroborated by actual cases
[8].
Deprivation of glutamine can retard the growth of a cancer [9]
but it is a complicated metabolism with both glucose and glu-
tamine required as the major ingredients for proliferating cells,
generating ATP and carbon for the synthesis of macromolecules
[10]. However, it is detrimental to the sufferer of cancer to reduce
intake of glutamine because the cancer begins to relinquish the
body of its stores, leading to muscle deterioration [11]. The gluta-
mate converted from gln will result in either nitrogen released
through NH3 or given up to amide nitrogen biosynthetic routes.
For successful proliferation of cells the biosynthetic activity has
to be directed at recreating macromolecular biostructures and this
need is met by an anabolic shuffle of cellular metabolic action [12].
Thus it is clear that there is a pronounced glutamine activity
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present for energy sustenance, the cancerous cells can survive on
glutamine very effectively. Therewith, we begin our discussion of
the connection to the skin, the nucleation of glutamine crys-
tallisation and skin markers such as EGR.Results
Epidermal barrier function and glutamine
Localisation of glutamate in the epidermis may lead to signa-
tures of pre-eminent biological discord in some individuals. In
the event of low glucose supplies a cancer adapts itself to glu-
tamine harvesting in order to maintain its development and
growth. Signatures of cancer may show in the event of mild skin
barrier damage or an allergic response of some form. Indeed skin
barrier disruption has been shown to cause the secretion of gluta-
mate shortly afterwards from the skin tissue [13]. The metabolic
systems in the epidermis could be regulated by glutamate recep-
tors. The skin cells for regulating and implementing an immune
response are macrophages, Langerhanse cells, monocytes and mast
cells. From the perspective of earlier prediction of cancer it was
recently shown that for pancreatic ductal adenocarcinoma that
there occurs an increase in branched chain amino acids even two
to five years before diagnosis [14]. This is further evidence that
biomarkers of cancer are to be found as alterations to the meta-
bolic state, with protein breaking down throughout the body to
feed the process.
We are interested in the development of the ring-like structures
that emerge severalweeks before the diagnosis of, for example, lung
cancer on the skin in some patients. We will show in the next sec-
tions that these rings are a characteristic of high levels of gln. The
shear abundance of gln in the body, higher than all other essential
amino acids combined [15], is important for ensuring cell viability.
The cutaneousmanifestations oftenmirror the health of the visceral
sites and metabolic effects due to tumour cells. EGR is not the only
early skin warning of a tumour, though it is known to be the most
strongly linked to an impending detection. Urticaria also commonly
appears, but can be associated with a range of allergic reactions and
so is not a definitive indicator of tumourigenesis [16].
In any case pattern signatures on the skin allow identification of
many underlying problems by those working in dermatology and
also in understanding cutaneous diseases at a microscopic level.
In EGR the patterns also appear to be marked by collision fronts
and a highly dynamic evolution with little by way of explanation
in the literature about its basis. Gilmore gives a chemical pre-pat-
terning hypothesis with a chemical gradient as a wave that spreads
out across the skin, calling upon dynamical symmetry breaking
concepts by way of explanation [17,18]. However, description of
the chemical pathways has not been elucidated and the mecha-
nisms of the condition remain unknown. Here, we hypothesise that
the mechanism is associated with a wave of cutaneous gln reac-
tion, based upon our experimental observations.Glutamine transport
Glutamine is composed of two side chains containing nitrogen,
one amide and an amino group, making it chemically suitable for
free flowing transport of nitrogen throughout the blood. Thus, it
ships ammonia through the peripheral tissues to be processed by
viscera, such as the liver, for removal [19]. The abnormal growth
of cells can eventually lead to neoplasia and for this to occur the
blood has to be rich in gln. Thus, the transport of glutamine
throughout the body becomes accelerated with metaplasia
occurring.In the development of lung cancer an irritant such as cigarette
smoke, polycyclic aromatic hydrocarbons [20,21] or even radon
gas [22] can eventually lead to the formation of metaplastic
regions that result in dysplasia and then neoplasia. Cancer cells
rely on glutamine to keep the tricarboxylic acid (TCA) cycle going
[23]. Aberrant cell proliferation occurs with the activation of onco-
genes such as pten and c-Myc, the switching off of the p53 tumour
suppressor, and the redirection of glutamine via the mTOR-sig-
nalling pathway [24]. Understanding the altered metabolism of
cancer and the development of an effective coupling between
organs with the movement of glutamine throughout the body
may be of benefit to create a decrease in resistance to apoptosis.
Ko et al. have shown very clearly that gln affects cells differentially
in the micro-environment of the tumour, with decreased autop-
hagy for the epithelial cells and the opposite in the stromal com-
partment [25] – gln uptake and release seems to be energetically
efficient in cancer cell proliferation, which in turn can lead to
new mechanical stresses on the micro-environment [26,27].
Thus, whereby the tumour may once have been perceived as
inefficient, it may be that new insights into the mechanisms of glu-
tamine transport and regulation are showing that there is more
purpose behind the drive for proliferation. One may even view
the tumour as a kind of glutamine pump with the whole body
becoming involved to some extent. The wave of glutamine would
appear to be tidal as Gilmore stated [17,18].
We now wish to present the crystallisation phenomena of gln,
which we have found are markedly different from those of other
amino acids. Glutamine will move across a substrate as a wave
as is shown in Fig. 1. In the intracellular fluid, especially of skeletal
muscle, the concentration of gln ranges between 10 and 30 mM
under normal conditions [28,29]. In circulation it is between 0.5
and 0.8 mM [28,29]. We are interested in abnormally high levels
of glutamine with respect to biological functionality, so we demon-
strate high concentration levels in aqueous solution (>20 mM).
Fig. 1 is used to illustrate the remarkable wave like characteristics
that occur in glutamine across a substrate. In Fig. 1(a) and (b) the
optical microscopy images show the formation of ripples and
domain boundaries that become evident as the evaporation occurs,
in a dynamic process that can be analogous to morphological
changes that emerge during dehydration of amino acid rich bio-liq-
uids close to the skin surface. The next two images of Fig. 1 show
large crystal structures that typically form close to interfaces
between materials or at points where there are surface defects.
Fig. 1(d) shows crystallisation in a blood sample at elevated con-
centrations. The process brings to mind the ‘‘Litos’’ test-system
that tries to discern underlying diseases through the drying of bio-
logical samples and the resulting self-organised structures that are
used to understand the metabolic state of organs [30].
Except that in the case of the skin the signatures are in clear evi-
dence through, for example, EGR. For levels of gln similar to that
found in the skeletal muscle, large crystal structures form around
the perimeter of a droplet or interfacial boundary with some areas
of clustered semi-circular concentric ringing. Fig. 2(a)–(d) show
this for a concentration of 20 ± 5 mM, where all pattern formation
has occurred at the edge, with a central region devoid of any wave-
like spreading or crystal nucleation. The edge of the droplet is rea-
sonably pinned to its original location throughout, giving a con-
stant contact-diameter where the larger crystals will tend to
form at all higher concentrations.
When the concentration is increased to 40 ± 5 mM, Fig. 3, the
effects remain bound to the perimeter, though the size of the crys-
tals do become larger. Small ‘‘buds’’ such as in Fig. 3(c) can emerge
and as the concentration increases these will act to direct the inter-
nal structural formations. These kinds of larger crystals always
nucleate first and can control the direction and onset of domain
structures (see e.g. Fig. 1(a)). With regards to crystallisation, there
Fig. 1. L-Glutamine crystallises as a wave through water. In (a) the formation of domains marked by collision fronts and the appearance of ring structures is apparent. (b) The
rings appear at junctures of the wavefronts, with larger crystals appearing at the periphery of a droplet or around a defect, as in (c). (d) Glutamine crystals developing in blood.
(e) Similar patterns emerge in erythema gyratum repens (left sketch) and the polycyclic rash is compared to the self-assembled glutamine structures (right).
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example, gout is a condition associated with concentrations of uric
acid in plasma that exceeds its solubility, forming monosodium
urate crystals (tophi) that lie under the skin. Thus, an increase in
concentration, perhaps through build up over time as in gout, leads
to larger crystal formation and for skin ailments greater inflamma-
tion. There has also been documented evidence of an association of
the appearance of EGR to rheumatoid arthritis [31]. Fig. 4 shows
that increasing the concentration of gln so that there is
65 ± 5 mM leads to enhancement of the peripheral crystal struc-
tures, whereas again a tidal like pattern moves inward from these
outer edges till a point where it stops in the interior of the stain.
We find that at a concentration of 90 ± 5 mM that the wave covers
the entire interior space with an absence of surface vacancies on
the higher scale. In the interior of a drop or between pinning sites
concentric rings appear with regularity at this concentration, as
shown in Fig. 5. These kinds of rings remind one of the incredible
patterns associated with some cases of EGR. These concentric
structures, with the appearance like beetroot rings, completely
self-organise within the regions relatively far away from the large
exterior crystals; such as those of the top picture in Fig. 4. To createrings such as these many methods have been employed in indus-
try, ranging from use of low frequency vibration to manipulation
with electromagnetic fields of fine particles. However, here the
rings form under a simple chemical energy pathway without com-
plex intervention. Thus, though the aim is to understand better the
mechanisms of skin conditions from elevated gln levels it is also
worth keeping in mind that there can be technological uses for this
kind of self-assembly and the diversity of amino acids [32]. Not
least of which is the creation of new optical devices such as
super-oscillatory lenses produced from concentric rings of
micrometre periodicity [33] or the surface layering of nanoparti-
cles [34,35]. However, for biological issues the appearance of rings
is particularly interesting as a function of concentration because of
EGR and other skin anomalies. In the Supplementary information
even higher concentrations of gln are investigated whereby
rectangular crystals appear.
Discussion
We have demonstrated the formation of self-organised patterns
that are associated with glutamine and its derivatives as a possible
Fig. 2. Concentric ring structures emerge at concentrations of 20 ± 5 mM of glutamine in water in the boundary of a droplet. (a)–(d) Show these structures at different
locations around the periphery.
Fig. 3. L-Glutamine at 40 ± 5 mM in water. (a) As in Fig. 2 the central region is devoid of crystallisation and only an outer perimeter exists. (b) The crystals become larger at the
outermost region compared to lower concentrations. These crystals can form as ‘‘buds’’ as in (c), whilst there are some more ring like structures at locations around the edge,
(d).
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as a consequence of tumour activity [6]. There are a few viewpoints
to the origin of EGR, including cross-react antibody theory [4].
The purpose of this paper is to suggest glutamine as the reason
for the unusual skin patterns and to prompt those with medical
facilities to carry out a more direct experimental set-up using the
actual skin or cutaneous cells to investigate the issue, for whichthe key molecules that forms ring structures in EGR remain
unknown.
The physiological mechanisms underlying the development of
skin rashes are highly complex. Interestingly, lamotrigine (a drug
associated with the treatment of epilepsy), also with H2N and
NH2 side groups is associated with skin rashes [36]. Taking a
broader picture, as well as epilepsy, neurological diseases [37] such
Fig. 4. Around the edge large crystals form (left). A wave-like formation is generated that moves inwards from the peripheral larger crystals (right). Always the edge crystals
become visible first. The concentration of gln in aqueous solution was 65 ± 5 mM.
Fig. 5. With a concentration of gln in H2O of 90 ± 5 mM concentric ring structures appear in the bulk regions of the droplets and between confinement regions.
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release of high levels of glutamate in the brain. The role of gluta-
mate has been extensively investigated by Teichberg and co-work-
ers with respect to its role as an excitatory neurotransmitter
[38,39]. In particular, it was discovered that glutamate is involved
in almost every role of healthy brain function and central nervous
system development. However, in some cases stroke may produce
a glutamate cascade that can cause irreversible damage to the
brain [40]. The increase in concentration of glu leads to the excito-
toxicity [39], again demonstrating the importance throughout the
body for regulation of these amino acid levels.
We know that there is a link between lung cancer and EGR and
we assert to the concept that glutamine metabolism is at the root.
Indeed it has been shown that glu may leak from the skin if it is
injured, leading to a higher occurrence of skin inflammation, with
Norkland et al. hypothesising that under stress the skin may com-
pensate to maintain sufficient levels of amino acids [41]. It has also
been known for a number of years that glu is not only a
neurotransmitter but also functions in signalling in non-neuronal
tissues, including keratinocytes in skin [42]. Importantly, ker-
atinocytes manufacture and release L-glutamate [43] continuouslyand uniformly throughout the epidermis. Thus, upon saturation of
the body with a glutamine related sequence of chemical reactions,
brought about by the hunger of a tumour, the appearance of skin
rashes seems highly plausible given the evidence of a delicately
balanced state for healthy functionality. Also, to compound the
problem, dermatitis lesions have also been linked to production
and liberation of excess glu [44]. Thus, the glutaminolytic path-
ways are essential for understanding cancer biology [29] and con-
sequently the complexity of the interactions occurring across
microscopic and macroscopic scales.
We have shown the relationship between advancing serpigi-
nous trails, with notable ring formations emerging as a function
of concentration in aqueous solution. It is now important to inves-
tigate further the relationships of the glutaminolysis, cancer cells
and the skin. For future work a clarification of how chemicals pene-
trate, accumulate and rise from beneath into the epidermis sub/in-
tra/extra-cellular compartments needs to be undertaken, with a
focus on amino acid units. This work may be undertaken using spe-
cialised two-photon microscopy which allows the detection of
specific cells, proteins and amino acids near the stratum corneum
whilst tracking substances as they are absorbed.
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enable the coupling of exergonic (negative Gibbs free energy
change: flow of energy from the system to the surroundings) and
endergonic processes (non-spontaneous absorbtion of work from
the environment to the system) that may not happen together or
be localised in the same tissue [45]. Thus, the view of glutamine
as a systemic-wide enabler of energy transfer is valid. We hope
that the work herein can offer valuable new insights into the role
of gln in skin signatures (e.g. EGR) of interior diseases such as lung
cancer.
It is also important for the development of new drugs or tech-
nologies that are designed for exploiting signal transduction theory
[27,46,47] to better understand the transport of glutamine inside
the body and how it can lead to adverse bio-responses when the
concentration becomes too high or low because it may be a tool
against cancer. In the biofunctionalisation of nanoparticles that
target cancer, surface coatings are essential to maximise their effi-
cacy and to even reduce their cytotoxicity in some cases [48]. Being
biocompatible also allows the clearance of nanoparticles from the
body in a natural way [49] and so surface preparation is crucial.
There is a high activity of crystallisation at the periphery of dro-
plets containing glutamine that can dictate the assembly of the
interior patterns that we have seen which may be used to coat a
surface. This is also true around an artificially induced defect or a
‘‘pinning’’ site (glutamine is particularly suited for creating artifi-
cial structures, an example of which is in Fig. S8 of the
Supplementary information, whereby a micro-square lattice was
prepared). Cytotoxicity also occurs with a dependency upon the
size of the crystals formed and thus concentration [50]. A different
perspective for the presented results is that the pattern formations
elucidated upon may be useful for the preparation of the outer lay-
ers of micro and nanoparticles as a function of concentration which
could be beneficial for creating pharmaceutical nanocarriers [51]
enveloped in glutamine.
Methods
Different concentrations of gln were prepared by addition to bi-
distilled water at room temperature and then sonicated for 6 min
at 46 kHz after centrifugation for 10 min at 1000 rpm. The solution
was then dropped, using micro-syringes, onto a clean soda-lime
glass slide, with a liquid–air interface. The air interface is deemed
valid for making comparisons to skin effects and the experiments
were conducted when the temperature of the slide reached 35 C
(measured with an infrared thermometer). The self-assembly was
monitored using optical microscopy (OM) and a digital camera
was attached to the lens. The surface of the substrate was scanned
manually for the concentration dependent formation of the rings
using OM.
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